LUSC has the second highest frequency of somatic mutations, including exon mutation genome rearrangement and copy number variation, which are significantly higher than those in lung adenocarcinoma.49Therefore, we performed TMB analysis on samples from different risk groups, and our results suggest that patients with LUSC have a favorable overall survival benefit from TTN and TP53 mutations. Here, TP53 is linked to lung adenocarcinoma.